Does Wave Life Sciences (WVE) Have the Potential to Rally 294.66% as Wall Street Analysts Expect?

Wave Life Sciences’ consensus price target implies 294.7% upside, though the note says this metric is largely ineffective. The near-term setup hinges on improving earnings estimate revisions, which could support an upside move in WVE despite the speculative nature of the signal.

Analysis

Wave Life Sciences’ consensus price target implies 294.7% upside, though the note says this metric is largely ineffective. The near-term setup hinges on improving earnings estimate revisions, which could support an upside move in WVE despite the speculative nature of the signal.